Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap

od Locke, Frederick L., Anasetti, Claudio
Izdano u J Immunother Cancer (2017)

Off-the-shelf TCR for graft-versus-leukemia without GVHD

od Locke, Frederick L., Anasetti, Claudio
Izdano u Blood (2018)

Beat pediatric ALL MRD: CD28 CAR T and transplant

od Ruella, Marco, Locke, Frederick L.
Izdano u Blood (2019)

A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction

od Chavez, Julio C., Locke, Frederick L.
Izdano u Mol Ther (2017)

CAR T cell therapy for B-cell lymphomas

od Chavez, Julio C., Locke, Frederick L.
Izdano u Best Pract Res Clin Haematol (2018)

Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma: A Review

od Locke, Frederick L., Go, William Y., Neelapu, Sattva S.
Izdano u JAMA Oncol (2020)

The roles of T cell competition and stochastic extinction events in chimeric antigen receptor T cell therapy

od Kimmel, Gregory J., Locke, Frederick L., Altrock, Philipp M.
Izdano u Proc Biol Sci (2021)

Immunotherapy strategies for multiple myeloma: the present and the future

od Locke, Frederick L, Nishihori, Taiga, Alsina, Melissa, Kharfan-Dabaja, Mohamed A
Izdano u Immunotherapy (2013)

Conditional deletion of PTEN in peripheral T cells augments TCR-mediated activation but does not abrogate CD28 dependency or prevent anergy induction

od Locke, Frederick L., Zha, Yuan-yuan, Zheng, Yan, Driessens, Gregory, Gajewski, Thomas F.
Izdano 2013

Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma

od Locke, Frederick L, Menges, Meghan, Veerapathran, Anandharaman, Coppola, Domenico, Gabrilovich, Dmitry, Anasetti, Claudio
Izdano u J Immunother Cancer (2015)

Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chro...

od Chavez, Julio C., Kharfan-Dabaja, Mohamed A., Kim, Jongphil, Yue, Binglin, Dalia, Samir, Pinilla-Ibarz, Javier, Anasetti, Claudio, Locke, Frederick L.
Izdano u Leuk Res (2014)

Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

od Maziarz, Richard T., Schuster, Stephen J., Romanov, Vadim V., Rusch, Elisha S., Li, Junlong, Signorovitch, James E., Maloney, David G., Locke, Frederick L.
Izdano u Blood Adv (2020)

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

od Schuster, Stephen J., Maziarz, Richard T., Rusch, Elisha S., Li, Junlong, Signorovitch, James E., Romanov, Vadim V., Locke, Frederick L., Maloney, David G.
Izdano u Blood Adv (2020)

Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients

od Hampras, Shalaka S., Locke, Frederick L., Chavez, Julio C., Patel, Nishit S., Giuliano, Anna R., Miller, Kyle, Gheit, Tarik, Tommasino, Massimo, Rollison, Dana E.
Izdano u Leuk Lymphoma (2017)

Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

od Kharfan-Dabaja, Mohamed A., Jain, Michael D., Aulakh, Sonikpreet, Ayala, Ernesto, Zubair, Abba C., Tun, Han W., Liu, Hien D., Locke, Frederick L., Chavez, Julio C.
Izdano u Am J Hematol (2019)

Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center Experience

od Kharfan-Dabaja, Mohamed A., Kumar, Ambuj, Stingo, Facundo E., Khimani, Farhad, Hussaini, Mohammad, Ayala, Ernesto, Nishihori, Taiga, Shah, Bijal, Locke, Frederick L., Pinilla-Ibarz, Javier, Chavez, Julio C.
Izdano u Clin Lymphoma Myeloma Leuk (2017)

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit ‘ALL’

od Neelapu, Sattva S., Tummala, Sudhakar, Kebriaei, Partow, Wierda, William, Locke, Frederick L., Lin, Yi, Jain, Nitin, Daver, Naval, Gulbis, Alison M., Adkins, Sherry, Rezvani, Katayoun, Hwu, Patrick, Shpall, Elizabeth J.
Izdano u Nat Rev Clin Oncol (2018)

Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease

od Frairia, Chiara, Nicolosi, Maura, Shapiro, Jamie, Kim, Jongphil, Betts, Brian C., Fernandez, Hugo F., Locke, Frederick L., Mishra, Asmita, Nishihori, Taiga, Ochoa-Bayona, Jose Leonel, Perez, Lia, Pidala, Joseph, Anasetti, Claudio
Izdano u Biol Blood Marrow Transplant (2020)

Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma

od Neelapu, Sattva S., Jacobson, Caron A., Oluwole, Olalekan O., Munoz, Javier, Deol, Abhinav, Miklos, David B., Bartlett, Nancy L., Braunschweig, Ira, Jiang, Yizhou, Kim, Jenny J., Zheng, Lianqing, Rossi, John M., Locke, Frederick L.
Izdano u Blood (2020)

Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft-versus-Host Disease: Phase I Trial Results

od Pidala, Joseph, Kim, Jongphil, Betts, Brian C., Alsina, Melissa, Ayala, Ernesto, Fernandez, Hugo F., Field, Teresa, Kharfan-Dabaja, Mohamed A., Locke, Frederick L., Mishra, Asmita, Nishihori, Taiga, Ochoa-Bayona, Leonel, Perez, Lia, Riches, Marcie, Anasetti, Claudio
Izdano u Biol Blood Marrow Transplant (2015)